Background Image
Table of Contents Table of Contents
Previous Page  162 / 772 Next Page
Information
Show Menu
Previous Page 162 / 772 Next Page
Page Background

16

The forecast from investment firm Grantham Mayo

Van Otterloo for projected asset-class returns is

widely anticipated within the investment industry,

even though it’s rarely sunny. At the Morningstar

Institutional Conference in early March, I sat down

with Ben Inker, co-head of the firm’s asset-allo-

cation team, to delve into the firm’s latest forecast.

Christine Benz:

Let’s start with

U.S.

equity today.

Generally speaking, it’s not a particularly optimistic

picture for

U.S.

equity.

Ben Inker:

We don’t much like

U.S.

stocks today, and

that’s because their valuations are trading at the

very high end of what we’ve seen historically.

U.S.

large-cap stocks don’t look as expensive as they

did in

2000

, but we’re trading at valuations today that

are higher than we saw at the market peak in

1929

or

1965

. We are trading at what we think of as upper-

20

s in terms of normalized earnings, which is really

quite expensive. If valuations are going to come back

to long-term averages

which is, let’s say,

16

or

17

times normalized earnings

that means, over the

next seven years, you’re unlikely to make money rela-

tive to inflation in

U.S.

stocks. So, we really don’t

much like them. They have been worse, but they’ve

spent most of their history much better.

Benz:

Are small caps particularly unattractive to

you today?

Inker:

Yeah, it’s one of the interesting things. Most of

the times in history when the S

&

P

500

has been at its

most expensive, it’s been a large-cap phenomenon.

2000

was an extreme example of that. It was only a

handful of stocks that were driving the very high valu-

ations in the S

&

P

500

, and so if you just looked at

the average stock in the

U.S.

, it was much less bad.

Today, we actually see something of the reverse.

U.S.

stocks look expensive to us, more or less across the

board. But if forced to own

U.S.

stocks, we’d rather

own the big ones. Smaller-cap stocks are trading

at higher valuations than we’ve really ever seen.

Again, they’re not as silly as the Internet stocks were

in

2000

, but we’ve seen a period of time where the

U.S.

economy has been outgrowing the rest of the

world by a significant margin.

U.S.

small caps tend to

be much more domestically focused. They tend to

be more leveraged than large-cap names, and they’ve

been big beneficiaries of very low interest rates. A

lot of things have gone their way. We don’t think that

things will continually go their way. And they’re

priced as if small caps are growth stocks, and the

reality is that the vast majority of small caps are

not growth.

Benz:

Again,

U.S.

stocks are not attractive overall

to you. But when you take a few different cuts of the

U.S.

market, a couple of pieces look slightly better.

Quality looks better to you. Let’s talk about how you

define quality.

Inker:

For us, quality stocks are companies that have

shown an ability to earn a high return on capital

across the economic cycle, where that return on

capital has been stable, and where the company has

been able to do that with low debt. Those are the

three key factors for us for quality. Now, those compa-

nies have some nice characteristics. They are much

less likely to go bust than the average company

because they are profitable and they don’t have debt.

They don’t outperform in the long run; there is no

particular reason why they should. They are probably

less risky; but today, in one of the few times in

history, they’re not trading at a premium. These guys

are actually trading at slightly lower P/Es than the

average stock, which is interesting because we think

they deserve a premium.

And particularly today, we think they would deserve

a premium because when we look at

U.S.

stocks

today, the most striking thing is that

U.S.

corporations

have almost never been more profitable. Profits, as

a percent of

GDP

, are near all-time highs. Returns on

invested capital look very good. We think they are

GMO Forecast Calls for Pain

Portfolio Matters

|

Christine Benz